New COPD drug combo shows promise in Short-Term symptom relief
Symptom relief
Completed
This study tested two medications, Taneasy and Fluimucil, taken twice daily for 14 days in 45 adults with COPD. The goal was to see if they safely reduce symptoms like cough and mucus. The main measure was the CAT score, which tracks how COPD affects daily life.
Phase: PHASE4 • Sponsor: Bun Yao Biotechnology Co., Ltd • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC